Immunoglobulin and T-cell receptor gene rearrangements: minding your B's and T's in assessing lineage and clonality in neoplastic lymphoproliferative disorders.
作者信息
Bagg Adam
机构信息
Department of Pathology and Laboratory Medicine, University of Pennsylvania, 7.103 Founders Pavilion, 3400 Spruce St., Philadelphia, PA 19104-4283, USA.
出版信息
J Mol Diagn. 2006 Sep;8(4):426-9; quiz 526-7. doi: 10.2353/jmoldx.2006.060108.
Abstract
摘要
相似文献
1
Immunoglobulin and T-cell receptor gene rearrangements: minding your B's and T's in assessing lineage and clonality in neoplastic lymphoproliferative disorders.
J Mol Diagn. 2006 Sep;8(4):426-9; quiz 526-7. doi: 10.2353/jmoldx.2006.060108.
2
3
Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
Am J Dermatopathol. 2006 Oct;28(5):399-409. doi: 10.1097/01.dad.0000211514.98230.ba.
4
Immunoglobulin and T-cell receptor genes reveal the clonality, lineage, and translocations of lymphoid neoplasms.
Important Adv Oncol. 1987:3-25.
5
T-cell receptor gene rearrangements and the diagnosis of human T-cell neoplasms.
Crit Rev Oncol Hematol. 1990;10(3):267-81. doi: 10.1016/1040-8428(90)90035-q.
6
Rearrangement of T-cell receptor delta chain gene as a marker of lineage and clonality in T-cell lymphoproliferative disorders.
Cancer Res. 1989 Aug 15;49(16):4488-92.
7
Primary T-cell lymphoma of the retina and cerebellum: immunophenotypic and gene rearrangement confirmation.
Am J Ophthalmol. 2009 Sep;148(3):350-60. doi: 10.1016/j.ajo.2009.04.005. Epub 2009 May 24.
8
Evaluation of Positive B- and T-Cell Gene Rearrangement Studies in Patients With Negative Morphology, Flow Cytometry, and Immunohistochemistry.
Arch Pathol Lab Med. 2021 Feb 1;145(2):227-230. doi: 10.5858/arpa.2019-0663-OA.
9
DNA rearrangements of cell lineage specific genes in lymphoproliferative disorders.
Prog Hematol. 1986;14:303-32.
10
Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.
Leukemia. 2003 Dec;17(12):2257-317. doi: 10.1038/sj.leu.2403202.
引用本文的文献
1
Primary Nodal Unclassifiable CD20 Negative Diffuse Large B-cell Lymphoma With Dual and Gene Rearrangement: A Diagnostic Challenge.
Clin Pathol. 2023 Jan 15;16:2632010X221149978. doi: 10.1177/2632010X221149978. eCollection 2023 Jan-Dec.
2
Feline and Canine Cutaneous Lymphocytosis: Reactive Process or Indolent Neoplastic Disease?
Vet Sci. 2022 Jan 11;9(1):26. doi: 10.3390/vetsci9010026.
3
CD3-CD20-positive nodal lymphoma with cross-lineage rearrangement in a dog.
J Vet Diagn Invest. 2020 Nov;32(6):964-967. doi: 10.1177/1040638720963132. Epub 2020 Oct 1.
4
Optimisation and validation of a PCR for antigen receptor rearrangement (PARR) assay to detect clonality in canine lymphoid malignancies.
Vet Immunol Immunopathol. 2016 Dec;182:115-124. doi: 10.1016/j.vetimm.2016.10.008. Epub 2016 Oct 19.
5
The DG75 B-cell lymphoma line exhibits biclonal immunoglobulin gene rearrangement.
Biomed Rep. 2013 Jan;1(1):111-114. doi: 10.3892/br.2012.22. Epub 2012 Oct 12.
6
The role of molecular pathology in the diagnosis of cutaneous lymphomas.
Patholog Res Int. 2012;2012:913523. doi: 10.1155/2012/913523. Epub 2012 Nov 19.
7
Primary mediastinal (thymic) large B cell lymphoma with aberrant expression of CD3: a case report with review of the literature.
Int J Hematol. 2010 Apr;91(3):509-15. doi: 10.1007/s12185-010-0501-4. Epub 2010 Feb 4.
8
Malleable immunoglobulin genes and hematopathology - the good, the bad, and the ugly: a paper from the 2007 William Beaumont hospital symposium on molecular pathology.
J Mol Diagn. 2008 Sep;10(5):396-410. doi: 10.2353/jmoldx.2008.080061. Epub 2008 Aug 7.
本文引用的文献
1
The frequency of B- and T-cell gene rearrangements and epstein-barr virus in T-cell lymphomas: a comparison between angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified with and without associated B-cell proliferations.
J Mol Diagn. 2006 Sep;8(4):466-75; quiz 527. doi: 10.2353/jmoldx.2006.060016.
2
Recombination activating genes (RAG) in lymphoma development.
Cell Cycle. 2006 May;5(9):913-6. doi: 10.4161/cc.5.9.2732. Epub 2006 May 1.
3
B lymphocytes on the front line of autoimmunity.
Autoimmun Rev. 2006 Mar;5(3):215-21. doi: 10.1016/j.autrev.2005.06.011. Epub 2005 Aug 16.
4
Biochemistry of V(D)J recombination.
Curr Top Microbiol Immunol. 2005;290:49-85. doi: 10.1007/3-540-26363-2_4.
5
Clonality detection of expanded T-cell populations in patients with multiple myeloma.
Methods Mol Med. 2005;113:257-67. doi: 10.1385/1-59259-916-8:257.
6
Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centres and a high content of EBV-infected large B-cells carrying IgH chain gene monoclonal rearrangement.
Histopathology. 2005 Apr;46(4):464-6. doi: 10.1111/j.1365-2559.2004.01997.x.
7
8
Clinical applications of molecular genetic testing in hematologic malignancies: advantages and limitations.
Hum Pathol. 2003 Apr;34(4):352-8. doi: 10.1053/hupa.2003.100.
9
Biology of Hodgkin's lymphoma.
Ann Oncol. 2002;13 Suppl 1:11-8. doi: 10.1093/annonc/13.s1.11.
10
Monitoring disease in lymphoma and CLL patients using molecular techniques.
Best Pract Res Clin Haematol. 2002 Mar;15(1):179-95. doi: 10.1053/beha.2002.0191.
Zotero 插件